Jae Ho Jung

15PUBLICATIONS
112CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersPsychosocial aspects of childbirth and perinatal mental healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 01, 2026
A Real-World Efficacy and Safety of KEYNOTE-522 Regimen in Patients With Early Triple-Negative Breast Cancer.

Shinyoung Lee, Hyehyun Jeong, Yeokyeong Shin

|Mar 31, 2026
Prognostic Significance of Pretreatment ¹⁸F-FDG PET/CT Parameters in Patients With ER+/HER2- Metastatic Breast Cancer Treated With CDK4/6 Inhibitors Plus Endocrine Therapy.

Minseung Suh, Jeongryul Ryu, Hojin Song

|Jan 09, 2026
TAPISTRY: A Phase II Study of Atezolizumab in Patients with Tumor Mutational Burden-High Tumors.

David M Thomas, Jeong Eun Kim, Fabrice Barlesi

|Sep 29, 2025
Prognostic Value of Neutrophil-Lymphocyte Ratio Change After Short-Term Chemotherapy in De Novo Stage IV Breast Cancer Patients.

Haena Shin, Sei-Hyun Ahn, Sae Byul Lee

|Sep 01, 2025
Research on the Emotional Stress of Pregnancy-Associated Breast Cancer Patients and Its Effects on Child developmenT: The RESPECT.

Ah Yoon Kim, Ju Yeon Kim, Jae Ho Jeong

|Aug 20, 2025
Proliferation of Tumor-Related Regulatory T Cells in Circulation Dictates Efficacy of Chemoimmunotherapy in Triple-Negative Breast Cancer.

Seung Hyuck Jeon, Koung Jin Suh, Sungmin Jung

Pageof 3

Frequent Collaborators

8 joint publications

Kyung Hae Jung

7 joint publications

Sung-Bae Kim

7 joint publications

Il-Yong Chung

6 joint publications

Gyungyub Gong